D-1327-2019 Class II Terminated

Recalled by Pharm D Solutions, LLC — Houston, TX

FDA drug recall D-1327-2019 was initiated by Pharm D Solutions, LLC on May 23, 2019 and is designated Class II. Reason for recall: Lack of Sterility Assurance. The recall status is terminated (terminated Feb 5, 2021). Affected quantity: 11 vials.

Recall details

Product Type
Drugs
Report Date
Jun 19, 2019
Initiation Date
May 23, 2019
Termination Date
Feb 5, 2021
Voluntary/Mandated
FDA Mandated
Product Quantity
11 vials

Product description

Ipamorelin Acetate 9 mg/9mL Injectable vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846

Reason for recall

Lack of Sterility Assurance.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 05022019:50 Exp. 10/29/2019; 05082019:91 Exp. 06/08/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1327-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1327-2019. Report a data issue: hello@regdatalab.com.